A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summary.
Chen
D
D
Chernik
D A
DA
Ellinwood
E
E
Hauri
P
P
Johnson
L C
LC
Judd
L L
LL
Kripke
D F
DF
Linnoila
M
M
Moskowitz
H
H
Roth
T
T
D000328:Adult; D000339:Affect / Q000187:drug effects; D001143:Arousal / Q000187:drug effects*; D002908:Chronic Disease; D004311:Double-Blind Method; D005479:Flurazepam / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D008874:Midazolam / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011597:Psychomotor Performance / Q000187:drug effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000097:blood / Q000188:drug therapy*; D012894:Sleep Stages / Q000187:drug effects*
D005479:Flurazepam; D008874:Midazolam